Results 171 to 180 of about 1,690,762 (327)

Teaching Internal Medicine Residents to Critically Appraise the Role of Race in Pulmonary Function Testing. [PDF]

MedEdPORTAL
Bhatia-Lin A, Bhakta N, Deshpande N, Granados L, Adamson R.   +4 more
europepmc   +1 more source

Comparative Analysis of Clinical Outcomes and Financial Aspects of Phototherapies and Immunotherapy for Cancer

Advanced Science, EarlyView.
This review compares clinical outcomes, translational progress, and global funding trends across cancer phototherapies—photodynamic, photothermal, and photoimmunotherapy—and conventional immunotherapy. It highlights differences in treatment efficacy, clinical trial status, financial investment, and regulatory challenges, providing a comprehensive ...
Deepak S. Chauhan, Kun Shao, Roopa Hebbandi Nanjundappa, Daniel‐Jiajun Yu, Marianne Stanford, Huile Gao, Channakeshava Sokke Umeshappa   +6 more
wiley   +1 more source

Pulmonary Function Testing in Healthy Infants in Rural Bangladesh: Feasibility Study. [PDF]

Pediatr Pulmonol
Verwey C, Sojib HGK, Islam MS, Roy AD, Islam MAA, Chowdhury NH, Czovek D, Makan G, Ahmed S, Baqui AH, Hantos Z, McCollum ED.   +11 more
europepmc   +1 more source

Addressing Race in Pulmonary Function Testing by Aligning Intent and Evidence With Practice and Perception. [PDF]

Chest, 2022
Bhakta NR, Kaminsky DA, Bime C, Thakur N, Hall GL, McCormack MC, Stanojevic S.   +6 more
europepmc   +1 more source

Irisin Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension via Ubiquitin‐Mediated Regulation of ENO1

Advanced Science, EarlyView.
Irisin is a crucial plasma biomarker and promising therapeutic target that reflects disease severity, pulmonary vascular remodeling status and clinical outcome in patients with pulmonary arterial hypertension (PAH). As a novel protective factor, irisin is downregulated in PAH. By ubiquitination, irisin promotes Enolase 1 degradation and suppresses cell
Na Sun, Yong‐Bing Wang, Jing Huang, Run‐Wei Deng, Hui‐Yu He, Lei Gao, Xuan Gao, You‐Li Fan, Yan Cong, Yao‐Lei Guo, Yi‐Qiang Chen, Gui‐Jia Wang, Shao‐Hong Fang, Xia Gu, Bo Yu, Bing‐Xiang Wu   +15 more
wiley   +1 more source

Pretreatment pulmonary function testing has limited utility in B-cell lymphoma treated with CD19 CAR T cells. [PDF]

Blood Adv
Sdayoor I, Shouval R, Fried S, Marcus R, Danylesko I, Yerushalmi R, Shem-Tov N, Itzhaki O, Jacoby E, Kedmi M, Nagler A, Shimoni A, Segel MJ, Avigdor A.   +13 more
europepmc   +1 more source

The Quantitative Computed Tomography Techniques are Alternate Modalities of Assessing the Disease Profile of COPD Instead of Pulmonary Function Testing Under COVID-19 Pandemic [Letter]. [PDF]

Int J Chron Obstruct Pulmon Dis, 2022
Teramoto S.
europepmc   +1 more source

Pulmonary function testing after operative stabilisation of the chest wall for flail chest [PDF]

, 2001
Didier Lardinois, Thorsten Krueger, Michael Dusmet, Nicola Ghisletta, Matthias Gugger, Hans‐Beat Ris   +5 more
openalex   +1 more source

Advanced Pharmaceutical Nanotechnologies Applied for Chinese Herbal Medicines

Advanced Science, EarlyView.
This review offers a comprehensive overview of pharmaceutical nanotechnology strategies to address limitations associated with the complex material basis and relative mild therapeutic efficacy of Chinese herbal medicines, and summarizes the advantages of these strategies.
Jiameng Li, Ya‐Li Zhang, Tong Jin, Zhaokui Jin, Mengliang Zhu, Guangchao Qing, Jinchao Zhang, Zhisen Wang, Yan Mu, Jin Li, Qian Hua, Xing‐Jie Liang   +11 more
wiley   +1 more source

Challenges and the Future of Pulmonary Function Testing in Chronic Obstructive Pulmonary Disease (COPD): Toward Earlier Diagnosis of COPD. [PDF]

Tuberc Respir Dis (Seoul)
Kim SH, Han MK.
europepmc   +1 more source